# TXA and Corona Virus 2019 (COVID19) in Outpatients

> **NCT04338074** · PHASE2 · TERMINATED · sponsor: **University of Alabama at Birmingham** · enrollment: 5 (actual)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** Tranexamic acid tablets
- **DRUG:** Placebo oral tablet

## Key facts

- **NCT ID:** NCT04338074
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-06-01
- **Primary completion:** 2021-04-21
- **Final completion:** 2021-04-21
- **Target enrollment:** 5 (ACTUAL)
- **Why stopped:** Lack of recruitment
- **Last updated:** 2021-05-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04338074

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04338074, "TXA and Corona Virus 2019 (COVID19) in Outpatients". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04338074. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*